Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mohamedali AM et al. – The data identify novel TET2 mutations in a dominant clone in patients with UPD4q24. The presence of UPD4q24 and mutations in RCMD–RS patients may suggest specificity to this subtype. The preliminary results need to be confirmed in a large cohort of all MDS subtypes.

Related Articles

Prognostic molecular markers in myelodysplastic syndromes
Expert Review of Hematology, 10/22/09    Relevance Score: 68%

Hematopoiesis-related microRNA expression in myelodysplastic syndromes
Leukemia and Lymphoma, 11/06/09    Relevance Score: 67%

Clinical significance of Th1/Th2 ratio in patients with myelodysplastic syndrome
International Journal of Laboratory Hematology, 10/28/09    Relevance Score: 66%

Accelerated cellular senescence in myelodysplastic syndrome
Experimental Hematology, 10/22/09    Relevance Score: 66%

Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression
Blood, 10/09/09    Relevance Score: 66%

Today in Basic Science/Genetics...keeping you current

Mutation analysis of the MSMB gene in familial prostate cancer
British Journal of Cancer, 12/10/09

Influence of omega-6 PUFA arachidonic acid and bone marrow adipocytes on metastatic spread from prostate cancer
British Journal of Cancer, 12/10/09

Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells
British Journal of Cancer, 12/10/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address